Add like
Add dislike
Add to saved papers

First study of susceptibility and resistance status to pyrethroids insecticides in Anopheles (Cellia) sergentii (Theobald, 1907) from Southern Tunisia.

Background: Insecticide resistance is an important threat to malaria control. Anopheles (An.) sergentii proved to be the number one vector in the oases and may be of a particular interest in projection of the future trends of the disease in Tunisia.

Objectives: Resistance status to pyrethroids insecticides in An. sergentii was evaluated for the first time in Tunisia.

Methods: Diagnostic resistance tests to pyrethroids insecticides were conducted on late third and early fourth larvae of An. sergentii collected in Southern Tunisia.

Results: The level of resistance to permethrin and deltamethrin varied from 1.9 to 5.77 and from 2.75 to 4.63, respectively. The highest resistance was recorded in sample # 3 to the two used insecticides. Synergists showed that esterases and glutathione-S-transferase were not involved in the resistance to any of the evaluated insecticides. In contrast, cytochrome-P450 monooxygenases played a role in the detoxification of two among three studied samples. Positive correlations between larval tolerance to both Permethrin/DDT and Deltamethrin/DDT were recorded indicated target site insensitivity.

Conclusion: Continued monitoring of insecticide susceptibility and generating complementary data on mechanisms of resistance using molecular and biochemical methods is essential to ensure early detection of insecticide resistance in potential malaria vectors in Tunisia.

Full text links

We have located links that may give you full text access.
Can't access the paper?
Try logging in through your university/institutional subscription. For a smoother one-click institutional access experience, please use our mobile app.

Related Resources

For the best experience, use the Read mobile app

Mobile app image

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

By using this service, you agree to our terms of use and privacy policy.

Your Privacy Choices Toggle icon

You can now claim free CME credits for this literature searchClaim now

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app